Question 1

What are the main strengths of investing in BHVN?

Accepted Answer

The main strengths of investing in Biohaven Pharmaceutical Holding Company Ltd. include: Strong commitment to ESG principles, Positive impact on society through innovative drug development, Transparent disclosure of ESG performance..

Question 2

What are the potential drawbacks of investing in BHVN?

Accepted Answer

Potential drawbacks of investing in Biohaven Pharmaceutical Holding Company Ltd. include: Relatively high financial risk, Limited track record in ESG performance..

Question 3

What are the key financial metrics for BHVN?

Accepted Answer

Key financial metrics for Biohaven Pharmaceutical Holding Company Ltd. include: Market Cap: $11.16 billion, Current Price: $427.43, Dividend Yield: 4.63%.

Biohaven Pharmaceutical Holding Company Ltd.

Detailed View

BHVN

ESG Ratings